Pharmaceutical Regulatory Affairs in the Middle East

This seminar will provide you with an essential overview of the key areas of pharmaceutical regulatory affairs in the Middle East.

18-19 Jun 2018

Book now

Course overview

Countries to be covered include: Bahrain, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Oman, Palestine, Qatar, Saudi Arabia, Sudan Syria, UAE, Yemen

BENEFITS OF ATTENDING THIS MEETING

  • Gain an Overview of the Regulatory Environment in the Middle East
  • Understand the Economic and Cultural Background to the Markets
  • Clarify Procedures for Company and Product Registration
  • Discuss Harmonisation and Recent Developments in the Region
    • Centralised Registration in the Gulf (GCC-DR)
    • Middle East Regulatory Conference (MERC)
    • MERC Follow-up Activities
    • Industry Regulatory Groups and Activities

Why you should attend

This seminar will provide you with an essential overview of the key areas of regulatory affairs in the Middle East. This two day course will focus on practical aspects to assist with regulatory affairs in the region. The course will include interactive discussion sessions to allow you to exchange experiences with other delegates.

Who should attend

This seminar will be of particular interest to:

  • Anyone involved in pharmaceutical regulatory affairs in the Middle East
  • Anyone new to the region
  • Anyone interested in an update of recent developments

Programme

This course will cover regulatory activities in- Bahrain, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Oman, Palestine, Qatar, Saudi Arabia, Sudan, Syria, UAE, Yemen

Each country presentation will cover the following topics:-

*The Pharmaceutical Regulatory Environment

  • Markets and Culture
  • Healthcare
  • Business Culture
  • Regulatory Environment and Characteristics
  • General Regulatory Requirements
  • Company and Product Registration
  • Variations and Renewals
  • Drug Classification
  • Regulatory Summary

Economic Overview of the Middle East

  • Population and GDP per capita
  • Unemployment rate
    GDP Real Growth Rate
    • Inflation Rate
    • Healthcare spend per capita

Following the country presentations, there will be presentations updating on developments in the Middle East as a region

Harmonisation and Recent Developments in the Region

  • Centralised Registration in the Gulf (GCC-DR)
  • Middle East Regulatory Conference (MERC)
  • MERC Follow Up Activities
  • Industry Regulatory Groups and Activities

Discussion will take place throughout the 2 days

Book now

18-19 Jun 2018
18-19 Jun 2018 Rembrandt Hotel, London
+ VAT @ 20.00%
Enrol now

You may also be interested in

Previous customers include...

  • Albayan Co
  • APOTEX PHARMACHEM INC
  • Aspen Healthcare FZ LLC
  • Bayer Pharma AG
  • BEAUFOUR IPSEN INTERNATIONAL
  • BOEHRINGER INGELHEIM GULF STATES
  • Bosnalijek d.d
  • C.B. FLEET COMPANY INC
  • CANA SA
  • CHIRON BV
  • FAES FARMA, S.A.
  • Gilead Sciences International Ltd
  • Ginsana SA
  • Helm AG
  • Hospira (ME & NA)
  • Janssen-Cilag Egypt
  • Liquent
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Menarini Biotech Srl
  • Met P Pharma AG
  • Mundipharma Laboratories GmbH
  • Mylan
  • Norgine Ltd
  • Owen Mumford Ltd
  • Pharma World
  • Pharmareg Consulting Ltd
  • Procter & Gamble Pharma UK Ltd
  • Sandoz
  • Sanofi-Aventis Recherche & Developpement
  • Statens Serum Institut